2019\u5e743\u670829\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ)\u306f\u3001³Ô¹Ï±¬ÁÏ Nitro<\/a><\/strong>\u306e\u5c0e\u5165\u304c\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306b\u304a\u3044\u3066\u52a0\u901f\u3057\u3066\u3044\u308b\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u306b\u7279\u5316\u3057\u305f\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u30c7\u30fc\u30bf\u30a6\u30a7\u30a2\u30cf\u30a6\u30b9\u3067\u3042\u308b³Ô¹Ï±¬ÁÏ Nitro\u306f\u3001\u30ab\u30b9\u30bf\u30e0\u30c7\u30fc\u30bf\u30a6\u30a7\u30a2\u30cf\u30a6\u30b9\u306b\u8cbb\u3084\u3055\u308c\u308b\u6642\u9593\u3068\u52b4\u529b\u3092\u524a\u6e1b\u3057\u3001\u4eba\u5de5\u77e5\u80fd(AI)\u3084\u9ad8\u5ea6\u306a\u5206\u6790\u306b\u3082\u5bfe\u5fdc\u3057\u3046\u308b\u57fa\u76e4\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u672c\u88fd\u54c1\u306e\u63d0\u4f9b\u958b\u59cb\u304b\u3089\u534a\u5e74\u3067\u30016\u793e\u304c³Ô¹Ï±¬ÁÏ Nitro\u306e\u63a1\u7528\u3092\u6c7a\u5b9a\u3057\u307e\u3057\u305f\u3002\u305d\u306e\u3046\u3061\u306e\u3001Karyopharm Therapeutics (NASDAQ : KPTI)\u793e\u304a\u3088\u3073MannKind (NASDAQ : MNKD)\u793e\u306e\u4e21\u793e\u3067\u306f\u3001\u3044\u305a\u308c\u3082³Ô¹Ï±¬ÁÏ Nitro\u30925\u304b\u6708\u4ee5\u5185\u3067\u7a3c\u50cd\u3055\u305b\u3066\u3044\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n <\/p>\n \u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u30d3\u30b8\u30cd\u30b9\u304c\u6025\u6210\u9577\u3092\u9042\u3052\u3001\u65b0\u3057\u3044\u6cbb\u7642\u6cd5\u304c\u5e02\u5834\u306b\u767b\u5834\u3059\u308b\u4e2d\u3067\u3001Karyopharm Therapeutics\u793e\u306f³Ô¹Ï±¬ÁÏ CRM<\/a><\/strong>\u306e\u30c7\u30fc\u30bf\u3084\u8acb\u6c42\u30c7\u30fc\u30bf\u306a\u3069\u306e\u591a\u69d8\u306a\u30c7\u30fc\u30bf\u30bb\u30c3\u30c8\u3092\u4e00\u3064\u306b\u307e\u3068\u3081\u3066\u3001\u73fe\u5834\u306e\u30c1\u30fc\u30e0\u304c\u9069\u5207\u306a\u60c5\u5831\u306b\u57fa\u3065\u3044\u3066\u9069\u5207\u306a\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u306b\u5230\u9054\u3067\u304d\u308b\u3088\u3046\u306b\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3057\u305f\u3002<\/p>\n Karyopharm Therapeutics\u793e\u3067\u30a8\u30f3\u30bf\u30fc\u30d7\u30e9\u30a4\u30ba\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u62c5\u5f53\u30b7\u30cb\u30a2\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3092\u52d9\u3081\u308bJason Magyar\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c³Ô¹Ï±¬ÁÏ Nitro\u306e\u304a\u304b\u3052\u3067\u3001\u30c7\u30fc\u30bf\u30a6\u30a7\u30a2\u30cf\u30a6\u30b9\u306e\u5b9f\u88c5\u306b\u304a\u3051\u308b\u591a\u304f\u306e\u8ab2\u984c\u304c\u89e3\u6c7a\u3055\u308c\u3001\u3088\u308a\u6709\u76ca\u3067\u30a2\u30af\u30b7\u30e7\u30ca\u30d6\u30eb\u306a\u30a4\u30f3\u30b5\u30a4\u30c8\u3092\u73fe\u5834\u306b\u63d0\u4f9b\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3057\u305f\u3002\u308f\u305a\u304b\u6570\u304b\u6708\u3067\u3001³Ô¹Ï±¬ÁÏ Commercial Cloud<\/a><\/strong>\u3084³Ô¹Ï±¬ÁÏ Nitro\u306e\u591a\u6570\u306e\u6a5f\u80fd\u3092\u5229\u7528\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u3063\u305f\u306e\u3067\u3059\u3002\u4ed6\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3060\u3068\u3001\u540c\u3058\u6a5f\u80fd\u3092\u5b9f\u73fe\u3067\u304d\u305f\u3068\u3057\u3066\u3082\u3001\u4f55\u5e74\u3082\u304b\u304b\u308b\u3053\u3068\u304c\u3042\u308a\u307e\u3059\u3002\u5f53\u793e\u306f\u3001\u6210\u9577\u3092\u4fc3\u3057\u3001\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30c8\u306a\u9867\u5ba2\u30a8\u30f3\u30b2\u30fc\u30b8\u30e1\u30f3\u30c8\u3092\u63a8\u9032\u3059\u308b\u305f\u3081\u306e\u3001\u78ba\u56fa\u305f\u308b\u57fa\u76e4\u3092\u5f97\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3057\u305f\u3002\u300d<\/p>\n ³Ô¹Ï±¬ÁÏ Nitro\u306f\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u7279\u6709\u306e\u30c7\u30fc\u30bf\u30e2\u30c7\u30eb\u3068\u6a19\u6e96\u30c7\u30fc\u30bf\u3092\u7d71\u5408\u3057\u3001\u305d\u308c\u306b\u3088\u3063\u3066\u51e6\u65b9\u7b8b\u3001\u58f2\u4e0a\u3001\u30d5\u30a9\u30fc\u30df\u30e5\u30e9\u30ea\u30fc\u3001\u8acb\u6c42\u30c7\u30fc\u30bf\u3068\u3044\u3063\u305f\u3001\u4f01\u696d\u306e\u6700\u3082\u91cd\u8981\u306a\u30c7\u30fc\u30bf\u30bd\u30fc\u30b9\u3082\u7d71\u5408\u3055\u308c\u307e\u3059\u3002\u30ab\u30b9\u30bf\u30e0\u30d3\u30eb\u30c9\u306e\u30c7\u30fc\u30bf\u30a6\u30a7\u30a2\u30cf\u30a6\u30b9\u306e\u4fdd\u5b88\u306b\u306f\u3001\u901a\u5e38\u3001\u591a\u5927\u306a\u52b4\u529b\u304c\u5fc5\u8981\u3068\u3055\u308c\u307e\u3059\u304c\u3001³Ô¹Ï±¬ÁÏ Nitro\u306e\u5834\u5408\u3001\u30c7\u30fc\u30bf\u69cb\u9020\u3084\u30c7\u30fc\u30bf\u30bd\u30fc\u30b9\u306b\u5909\u66f4\u304c\u3042\u3063\u305f\u969b\u306f\u30c7\u30fc\u30bf\u304c\u81ea\u52d5\u7684\u306b\u66f4\u65b0\u3055\u308c\u308b\u305f\u3081\u3001\u305d\u306e\u3088\u3046\u306a\u52b4\u529b\u304c\u5927\u5e45\u306b\u524a\u6e1b\u3055\u308c\u308b\u3053\u3068\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n \u5206\u6790\u306b\u5bfe\u5fdc\u3059\u308b³Ô¹Ï±¬ÁÏ Nitro\u306b\u306f\u3001\u4f01\u696d\u304c\u597d\u307f\u306e\u30d3\u30b8\u30cd\u30b9\u30a4\u30f3\u30c6\u30ea\u30b8\u30a7\u30f3\u30b9\u3084AI\u30c4\u30fc\u30eb\u3092\u4f7f\u7528\u3067\u304d\u308b\u67d4\u8edf\u6027\u304c\u3042\u308a\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ CRM MyInsights<\/a><\/strong>\u3068\u306e\u30b7\u30fc\u30e0\u30ec\u30b9\u306a\u7d71\u5408\u306b\u3088\u308a\u3001³Ô¹Ï±¬ÁÏ Nitro\u306e\u30c7\u30fc\u30bf\u306b\u5909\u66f4\u304c\u3042\u308c\u3070\u3001³Ô¹Ï±¬ÁÏ CRM MyInsights\u306b\u3044\u3064\u3067\u3082\u81ea\u52d5\u7684\u306b\u540c\u671f\u3055\u308c\u307e\u3059\u3002\u305d\u308c\u306b\u3088\u308a\u3001\u304a\u5ba2\u69d8\u306f\u73fe\u5834\u306e\u30c1\u30fc\u30e0\u306b\u5fdc\u3058\u305f\u30a4\u30f3\u30b5\u30a4\u30c8\u3092\u30c1\u30fc\u30e0\u304c\u6d3b\u50cd\u3057\u3066\u3044\u308b\u307e\u3055\u306b\u305d\u306e\u5834\u6240\u3078\u3001\u3042\u3089\u3086\u308b\u30e2\u30d0\u30a4\u30eb\u6a5f\u5668\u3092\u901a\u3058\u3066\u9001\u308a\u5c4a\u3051\u3089\u308c\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3057\u305f\u3002<\/p>\n \u7cd6\u5c3f\u75c5\u306a\u3069\u306e\u60a3\u8005\u7528\u6cbb\u7642\u85ac\u3092\u624b\u304c\u3051\u308b\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u306eMannKind\u793e\u3067\u30bb\u30fc\u30eb\u30b9\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u62c5\u5f53\u30a2\u30bd\u30b7\u30a8\u30fc\u30c8\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3092\u52d9\u3081\u308bAndrew Zepfel\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c³Ô¹Ï±¬ÁÏ Nitro\u306e\u304a\u304b\u3052\u3067\u3001\u30c7\u30fc\u30bf\u30a6\u30a7\u30a2\u30cf\u30a6\u30b9\u3092\u8fc5\u901f\u304b\u3064\u52b9\u7387\u7684\u306b\u69cb\u7bc9\u3057\u3001\u69cb\u6210\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3057\u305f\u3002\u3053\u306e\u88fd\u54c1\u304c\u3042\u308c\u3070\u3001\u696d\u52d9\u4e0a\u306e\u5909\u66f4\u304c\u751f\u3058\u3066\u3082\u8fc5\u901f\u306b\u5bfe\u5fdc\u3057\u7d9a\u3051\u308b\u3053\u3068\u304c\u3067\u304d\u3001\u307e\u305f\u3001\u9ad8\u5ea6\u306a\u5206\u6790\u3092\u884c\u3046\u305f\u3081\u306e\u57fa\u76e4\u3082\u5f97\u3089\u308c\u308b\u3067\u3057\u3087\u3046\u3002\u300d<\/p>\n ³Ô¹Ï±¬ÁÏ Nitro\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u306eAndy Fuchs\u306f\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u67d4\u8edf\u6027\u304c\u306a\u304f\u65e7\u614b\u4f9d\u7136\u3068\u3057\u3066\u3044\u308b\u305f\u3081\u306b\u9069\u5207\u306a\u30a4\u30f3\u30b5\u30a4\u30c8\u3092\u4f01\u696d\u306b\u63d0\u4f9b\u3067\u304d\u306a\u3044\u30ab\u30b9\u30bf\u30e0\u30c7\u30fc\u30bf\u30a6\u30a7\u30a2\u30cf\u30a6\u30b9\u306f\u3001\u9577\u304d\u306b\u308f\u305f\u3063\u3066\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306e\u8db3\u304b\u305b\u3068\u306a\u3063\u3066\u304d\u307e\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ Nitro\u306b\u3088\u3063\u3066\u3001\u4f01\u696d\u306f\u3064\u3044\u306b\u30d7\u30ec\u30d3\u30eb\u30c8\u578b\u306e\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u30c7\u30fc\u30bf\u30a6\u30a7\u30a2\u30cf\u30a6\u30b9\u3092\u5229\u7528\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u3063\u305f\u306e\u3067\u3059\u3002\u3053\u306e\u30c7\u30fc\u30bf\u30a6\u30a7\u30a2\u30cf\u30a6\u30b9\u306f\u8fc5\u901f\u306b\u5c0e\u5165\u3067\u304d\u308b\u3046\u3048\u3001\u3053\u308c\u307e\u3067\u306b\u306f\u3042\u308a\u3048\u306a\u304b\u3063\u305f\u30b9\u30d4\u30fc\u30c9\u3067\u5e38\u306b\u6700\u65b0\u306e\u30a4\u30f3\u30b5\u30a4\u30c8\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u300d<\/p>\n ³Ô¹Ï±¬ÁÏ Nitro\u306f\u5317\u7c73\u3068\u65e5\u672c\u3067\u63d0\u4f9b\u304c\u958b\u59cb\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u30e8\u30fc\u30ed\u30c3\u30d1\u3067\u3082\u30012019\u5e74\u306e\u4e2d\u3054\u308d\u304b\u3089\u63d0\u4f9b\u3055\u308c\u308b\u4e88\u5b9a\u3067\u3059\u3002<\/p>\n <\/p>\n \u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011 \u3010Forward-looking Statements\u3011<\/strong> 2019\u5e743\u670829\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751…<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-42437","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study","blog-product-data","blog-product-veeva-commercial-cloud","blog-product-veeva-crm"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42437"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=42437"}],"version-history":[{"count":3,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42437\/revisions"}],"predecessor-version":[{"id":42440,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42437\/revisions\/42440"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=42437"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=42437"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=42437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/strong>³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067700\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended October 31, 2018. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"